Epitalon vs GHRP-2
Both Epitalon and GHRP-2 are used for anti-aging. Here's how their evidence, dosing, and regulatory status actually compare.
Epitalon
Evidence C+Epitalon (Epithalon, AEDG)
A synthetic tetrapeptide that reportedly upregulates telomerase activity. Russian longevity studies suggest mortality reductions but Western RCTs are absent.
View full Epitalon profile →GHRP-2
Evidence BGrowth Hormone Releasing Peptide 2
A potent synthetic ghrelin-mimetic GH secretagogue. Drives strong GH spikes but raises cortisol and prolactin more than newer alternatives like Ipamorelin.
View full GHRP-2 profile →Side-by-Side
| Attribute | Epitalon | GHRP-2 |
|---|---|---|
| Evidence Grade | C+ | B |
| FDA Status | Not FDA-approved — Russian-origin research peptide | Not FDA-approved — research compound; previously studied as growth hormone deficiency diagnostic |
| Typical Dose | 5–10 mg daily for 10–20 days, cycled (subcutaneous) | 100–300 mcg, 1–3 times daily (subcutaneous) |
| Clinics Indexed | 47 | 86 |
| Categories | anti-aging, longevity | growth-hormone, anti-aging |
Key reported benefits — Epitalon
- ✓Telomerase upregulation (preclinical)
- ✓Sleep/circadian normalization
- ✓Anti-aging signals
Key reported benefits — GHRP-2
- ✓Strong GH release
- ✓Appetite stimulation
- ✓Muscle recovery
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.